Investigation of Corneal Aberrations and Visual Outcomes in Patients Implanted With an AcrySof Toric Intraocular Lens (IOL)

Status

Withdrawn

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00878839

Enrollment

Registered

2009-04-09

Start date

2009-03-31

Completion date

2009-03-31

Last updated

2012-08-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cataracts, Astigmatism

Keywords

Cataract, Toric IOL, Corneal Aberration, Astigmatism, AcrySof

Brief summary

A prospective evaluation of postoperative corneal aberrations and visual parameters (e.g. visual acuity) in patients implanted with an AcrySof Toric IOL.

Interventions

DEVICEToric

AcrySof Toric IOL

Study design

Allocation

NON_RANDOMIZED

Intervention model

SINGLE_GROUP

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to 70 Years

Healthy volunteers

Inclusion criteria

* Operable cataracts; * Good ocular health; * Qualifies for AcrySof Toric IOL via AcrySof Toric Calculator (1.03-2.06 D cylinder at corneal plane)

Exclusion criteria

* \>2.06 D astigmatism at corneal plane; * irregular astigmatism; * prior or ongoing corneal disease or scarring; * history of ocular disease

Design outcomes

Primary

Measure	Time frame
Corneal Aberration	3 months

Secondary

Measure	Time frame
Visual acuity, residual refractive cylinder, lens alignment	3 months

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026